Amerise Biosciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2016
Operating Revenue	-	-	-	-	90.08	-	Upgrade
Other Revenue	3.64	1.88	0.36	0.09	5.69	-1.69	Upgrade
Revenue	3.64	1.88	0.36	0.09	95.77	-1.69	Upgrade
Revenue Growth (YoY)	916.76%	423.68%	307.95%	-99.91%	-	-	Upgrade
Cost of Revenue	-	-	-	-	89.15	-	Upgrade
Gross Profit	3.64	1.88	0.36	0.09	6.63	-1.69	Upgrade
Selling, General & Admin	1.39	1.02	0.7	0.2	0.53	0.47	Upgrade
Other Operating Expenses	1.6	0.78	1.12	1.54	0.6	0.63	Upgrade
Operating Expenses	2.99	1.8	1.82	1.75	1.13	1.68	Upgrade
Operating Income	0.66	0.08	-1.46	-1.66	5.5	-3.37	Upgrade
Other Non Operating Income (Expenses)	-0	-0	-0	-0	-0	-	Upgrade
EBT Excluding Unusual Items	0.65	0.08	-1.46	-1.66	5.49	-3.37	Upgrade
Pretax Income	0.65	0.08	-1.46	-1.66	5.49	-3.37	Upgrade
Income Tax Expense	0.02	0.02	-	-0.47	-	-	Upgrade
Net Income	0.63	0.06	-1.46	-1.19	5.49	-3.37	Upgrade
Net Income to Common	0.63	0.06	-1.46	-1.19	5.49	-3.37	Upgrade
Shares Outstanding (Basic)	21	66	66	66	66	66	Upgrade
Shares Outstanding (Diluted)	21	66	66	66	66	66	Upgrade
EPS (Basic)	0.03	0.00	-0.02	-0.02	0.08	-0.05	Upgrade
EPS (Diluted)	0.03	0.00	-0.02	-0.02	0.08	-0.05	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	6.92%	-	Upgrade
Operating Margin	18.00%	4.15%	-405.85%	-1884.09%	5.74%	-	Upgrade
Profit Margin	17.39%	3.03%	-406.96%	-1351.14%	5.73%	-	Upgrade
EBIT	0.66	0.08	-1.46	-1.66	5.5	-3.37	Upgrade
EBIT Margin	18.00%	4.15%	-	-	5.74%	-	Upgrade
Effective Tax Rate	2.91%	25.00%	-	-	-	-	Upgrade
Revenue as Reported	3.64	1.88	0.36	0.09	95.77	-1.69	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.